Glottis IPO GMP: Glottis’ Rs 307 crore IPO has entered its second day of bidding, closing Day 1 at 42% subscription with bids for 84.72 lakh shares against 2.01 crore on offer. Grey market trading shows a 5.4% premium, down from 9% on Day 1. Priced at Rs 120–129, the IPO will remain open until...Read More

Indian Railway Finance Corporation (IRFC) has inked two loan agreements worth Rs 16,489 crore with Maharashtra and Haryana state utilities to fund thermal power expansion projects. The Rs 10,560 crore deal with MAHAGENCO will support Koradi’s 1,320 MW expansion, while Rs 5,929 crore with HPGCL will aid Yamunanagar’s 800 MW unit, reinforcing IRFC’s role as...Read More

The Nifty 50 index is set for a major September 2025 rejig, with IndiGo and Max Healthcare joining to attract over $1 billion in passive flows. Hero MotoCorp and IndusInd Bank will exit, while several other prominent stocks will experience significant weightage adjustments, impacting their respective inflows and outflows.Read More

Manju Yagnik highlights India’s growing real estate affordability challenge, with rising property prices making homes below Rs 1 crore scarce in Tier-1 cities. Despite this, the sector is projected for significant growth, driven by urbanization and strong residential sales, while sustainability and private equity inflows shape its future trajectory.Read More

A total of 13 Nifty500 stocks, including Wockhardt, Shree Cement, JSW Energy, and Bandhan Bank, closed above their 200 DMA on September 29, signaling bullish momentum.Read More

Post ContentRead More

Tata Motors share price: Moody’s downgraded Tata Motors’ outlook to negative after a cyberattack at JLR halted production. The company’s FY26 EBITDA is expected to take a massive hit due to this attack. While JLR has started a phased restart, prolonged disruptions could further affect earnings and cash flows, Moody’s added.Read More

Seven large-cap stocks, including Power Finance Corporation, LIC, PNB, and Bajaj Finserv, showed a bullish RSI upswing on September 29, signaling strengthening momentum.Read More

Aptus Pharma will debut on the BSE SME platform on September 30. Its initial public offering closed with high investor participation. The IPO was subscribed over 22 times across categories. Retail and high net worth individuals showed significant demand. The company distributes pharmaceutical formulations. It reported revenue and profit growth. Proceeds will fund working capital...Read More

Six NSE stocks, including Subros, Usha Martin, Lumax Industries, and Indian Bank, hit fresh 5-year swing highs on September 29, signalling bullish momentumRead More